U.S. FILLED & FINISHED | ≥99% COA-VERIFIED PURITY
LC-MS VERIFIED IDENTITY | INDEPENDENTLY TESTED

BPC-157 is likely the single most-searched research peptide in this field, and also one of the most misrepresented. This guide lays out what BPC-157 actually is, where it comes from, what mechanisms researchers have proposed, and an honest accounting of how much of that evidence comes from animal models versus humans.
BPC-157 is one of the most extensively studied research peptides available today, and also one of the most frequently overstated. This overview lays out where the compound actually comes from, what mechanisms have been proposed to explain its effects, and, honestly, how much of that picture is built on animal data versus human evidence.
BPC-157 stands for Body Protection Compound-157, a 15-amino-acid pentadecapeptide. The name traces to 1993, when a research team led by Sikirić isolated a novel protein of roughly 40,000 daltons from human gastric juice and named it BPC. Within that larger protein, the team identified and fully characterized a 15-amino-acid fragment, designated BPC-157, that carried the parent protein’s activity [1]. For more on how this and other peptide names come about, see our overview of peptide nomenclature.
Research framing: This article is intended for educational and research-context discussion only. BPC-157 is a research compound sold for laboratory investigation only. This content does not provide medical advice, dosing guidance, or treatment recommendations of any kind.
BPC-157’s research profile centers on a small number of interconnected pathways that repeatedly show up across the preclinical literature.
Research has linked BPC-157 to upregulation of vascular endothelial growth factor (VEGF) and its receptor, supporting new blood vessel formation in injured tissue [4].
Studies report BPC-157 activates endothelial nitric oxide synthase (eNOS), contributing to vascular tone regulation and tissue protection.
BPC-157’s effects on wound healing have been linked to modulation of the early growth response-1 (egr-1) gene, an immediate-response gene tied to angiogenic signaling.
In tendon research models, BPC-157 has been connected to focal adhesion kinase and paxillin signaling, a pathway fibroblasts use to migrate into a healing wound [3].
The largest, most consistent body of BPC-157 research covers gastrointestinal cytoprotection, the original context in which it was isolated, and tendon, ligament, and muscle repair [2,3]. Additional preclinical work extends into blood vessel and vascular research, and a smaller body of literature has examined central nervous system and gut-brain axis models.
A separate 2025 narrative review searching multiple databases through March of that year identified only three small human pilot studies involving BPC-157: one on intra-articular knee pain, one on interstitial cystitis, and one examining intravenous safety and pharmacokinetics. The review’s authors concluded that despite broad and reproducible preclinical support, human evidence remains inadequate to support clinical recommendations, and called for properly designed randomized controlled trials before BPC-157 could be considered an evidence-based intervention [5].
This gap between preclinical breadth and human evidence is not unusual for an investigational compound, but it is worth stating plainly rather than glossing over. BPC-157 is not FDA-approved for any use, and it was placed on the World Anti-Doping Agency’s prohibited list in 2022.
A meaningful share of the foundational BPC-157 literature, including much of the original characterization and mechanism work, originates from a single research group. That concentration of authorship is a reasonable factor to weigh when reading the wider body of BPC-157 research, alongside the preclinical-to-human evidence gap described above.
For how BPC-157 compares directly to TB-500, and why the two are so often studied together, see our guides on BPC-157 vs TB-500 and BPC-157 and TB-500 research.
Badger Compounds supplies BPC-157 as a lyophilized research peptide, six-round independently tested per batch with publicly viewable COAs. For qualified laboratory research use only.
View BPC-157Badger Compounds Research Access
This catalog is reserved for qualified research use. Confirm below to continue.
Please confirm both statements and select a research type.